相关实验视频

Updated: Jan 9, 2026

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Published on: March 15, 2024

在B细胞急性淋巴细胞白血病中,PRDX1的减弱会通过抑制cAMP通路导致铁亡

FangFang Zhong¹, Yan Zeng², Jing Liu²

¹Department of Pediatrics, Children Hematological Oncology and Birth Defects Laboratory, The Affiliated Hospital of Southwest Medical University, Sichuan Clinical Research Center for Birth Defects, Luzhou City, Sichuan, China. zff86@swmu.edu.cn.

Cancer gene therapy

|December 5, 2025

概括

过氧化素1 (PRDX1) 缺乏抑制B细胞急性淋巴细胞白血病 (B-ALL) 的生长,通过通过cAMP途径促进铁亡. 这一发现为B-ALL病原体和潜在的治疗点提供了新的见解.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
生物化学生物化学

背景情况:

B细胞急性淋巴细胞白血病 (B-ALL) 是一个重要的儿科血液恶性瘤.
确定参与B-ALL进展的关键基因和途径对于开发有效治疗非常重要.

研究的目的:

在B-ALL中选枢纽基因.
为了研究百氧化素1 (PRDX1) 在B-ALL中调节铁亡的作用.
阐明连接PRDX1,铁和B-ALL中的cAMP通路的潜在分子机制.

主要方法:

对GSE17703和GSE48558数据集进行生物信息学分析,以确定关键基因.
功能性试验评估PRDX1删除/过度表达对B-ALL细胞和异种移植瘤的影响.
转录组测序和分子分析,以评估铁亡标记物和cAMP通路的参与.

主要成果:

确定了四个关键基因;发现PRDX1显著影响B-ALL细胞的增殖,迁移和入侵.
减少PRDX1增强了埃拉斯诱导的铁亡,由增加的活性氧物种 (ROS),马隆迪甲基 (MDA) 和特定蛋白质标记物 (COX2,ACSL4) 证明,同时降低了保护因子 (GPX4,GSH,SOD).
缺乏PRDX1抑制了B-ALL细胞活力和异种移植瘤生长,与抑制cAMP通路的机制有关.

结论:

在B-ALL的进展中,PRDX1起着至关重要的作用.
通过抑制cAMP通路,PRDX1缺乏会诱导B-ALL细胞中的铁亡.
准PRDX1或cAMP通路为B-ALL提供了一个新的治疗策略.

更多相关视频

Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts

Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts

Published on: February 23, 2024

Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line

Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line

Published on: May 10, 2017

相关概念视频

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

Necrosis

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...

The Intrinsic Apoptotic Pathway

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...